CAPTURE your learning


Our resources are free to access. Log in and record your professional development using our CAPTURE function (at the bottom of each article).

At He Ako Hiringa our mission is to contribute to eliminating inequitable access to funded medicines.

Our latest content

10 minutes to Read + 2 minutes to Watch

Rosuvastatin is now fully funded on Special Authority for people at increased risk of cardiovascular complications due to high cholesterol, and may be considered first-line for Māori and Pacific peoples.

An abridged version of this article, containing the eligibility flowchart, is available for printing - see the link in the contents box. 

Contributor
He Ako Hiringa
15 November 2021
30 minutes to Watch

This video demonstrates how the three-step Ask, Build, Check health literacy model can be incorporated into discussions about the long-term management of gout, to help improve patient outcomes.

Please note that this is the video version of the Legendary Conversations podcast Episode Four: Let's talk gout (part 2).

Contributor
He Ako Hiringa
30 November 2021
30 minutes to Listen

This podcast demonstrates how the three-step Ask, Build, Check health literacy model can be incorporated into discussions about the long-term management of gout, to help improve patient outcomes.

Please note that this is the podcast version of the video Let's talk gout.

Contributor
He Ako Hiringa
30 November 2021
30 minutes to Listen

Episode three of our Legendary Conversations podcast is out now! Listen to three experts as they discuss attitudes towards gout and how to better communicate with patients to improve gout outcomes. 

Contributor
Professor Nicola Dalbeth, Carla White, Meihana Douglas
26 November 2021
11 minutes to Listen

Episode two of our Legendary Conversations podcast is out now! Listen to a scripted discussion that uses the Ask, Build, Check health literacy model when talking with a patient about starting a new medicine.

Contributor
He Ako Hiringa
28 October 2021
1 minute to Read

Prescribers are instrumental in framing a medicine positively or negatively, setting patient expectations. Optimising these expectations during a short consult can enhance and sustain benefits. Conversely, highlighting negative information may lead to increased experience, and reporting, of adverse events, and to poor adherence.

Contributor
He Ako Hiringa
26 November 2021

Thirsty for knowledge?

Subscribe to our newsletter to remain up to date with all our content and new features.